Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Streptococcus pneumoniae

ABSTRACT: Analysis of Streptococcus pneumoniae serotype 20 strains in Alberta, Canada

PROVIDER: PRJNA320861 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21332811_1.fastq.gz	Fastqsanger.gz
	SRR21332811_2.fastq.gz	Fastqsanger.gz
	SRR21332812_1.fastq.gz	Fastqsanger.gz
	SRR21332812_2.fastq.gz	Fastqsanger.gz
	SRR21332813_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 556

Similar Datasets

Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms

Project description:Diagnostic primer extension assay to serotype Streptococcus pneumoniae. Assay validation. Background: Monitoring of Streptococcus pneumoniae serotype epidemiology is essential since serotype replacement is a concern when introducing new polysaccharide-conjugate vaccines. To simplify S. pneumoniae serotyping, a novel PCR-based automated microarray assay was developed to assist in the tracking of the serotypes. Results: Autolysin (lytA), pneumolysin (ply) and eight genes located in the capsular operon (cps) were amplified using multiplex PCR. This step was followed by a tagged fluorescent primer extension step targeting serotype-specific polymorphisms. The tagged primers were then hybridized to a microarray. Results were exported to an expert system that transforms genetic typing data into capsular serotype identification. The assay was validated on 166 cultured S. pneumoniae samples from 63 different serotypes as determined by the Quellung method. In addition, the assay was tested on clinical specimens including 43 cerebrospinal fluid samples from patients with meningitidis and 59 nasopharyngeal aspirates from bacterial pneumonia patients. The assay presented with no cross-reactivity for 24 relevant bacterial species found in these types of samples. The limit of detection for serotyping and S. pneumoniae detection was 100 genome equivalent per reaction. Conclusion: This automated assay is amenable to clinical testing and does not require any culturing of the samples. The assay will be useful for the evaluation of serotype prevalence changes after new conjugate vaccines introduction. 166 quellung serotyped strains and two negative controls

2013-12-31 | E-GEOD-45865 | biostudies-arrayexpress

Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms

2013-12-31 | GSE45865 | GEO

RNAseq analysis of blood after co-infection with influenza virus and Streptococcus pneumoniae

Project description:Mouse blood transcriptome after infection with Influenza A virus (H1N1, PR/8/34, mouse-adapted) and Streptococcus pneumoniae (serotype 19F, strain BHN 100) Results: Differentially expressed genes were observed after single and co-infection Project: COST_mouse_2021

2022-08-31 | GSE194371 | GEO

Mouse lung gene expression after co-infection with influenza virus and Streptococcus pneumoniae

Project description:Mouse lung RNAseq after infection with Influenza A virus (H1N1, PR/8/34, mouse-adapted) and Streptococcus pneumoniae (serotype 19F, strain BHN 100) Results: Differentially expressed genes were observed after single and co-infection Project: COST_mouse_2021_lung

2022-08-31 | GSE196708 | GEO

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae

Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This submission pertains to Streptococcus pneumoniae strains 4496, 947, 4559, 180-2 and 180-15.

2021-07-05 | PXD017606 | Pride

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae 947

2021-07-01 | GSE152965 | GEO

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae 4496

2021-07-01 | GSE152828 | GEO

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae 4559

2021-07-01 | GSE152827 | GEO

Streptococcus pneumoniae. Two-color microarray bases Gene Expression Analysis v.6.5

Project description:TIGR4 and R6 bacterial strains of Streptococcus pneumoniae treated and not treated with the iron chelator deferoxamine mesylate (DFO)

2018-01-27 | GSE109693 | GEO

Transcriptomic analysis of the planktonic growth of Streptococcus pneumoniae serotype 1 reveals serotype-specific gene regulation

Project description:Streptococcus pneumoniae is an opportunistic pathogen that colonizes the mucosal surfaces of the human upper respiratory tract. To the exception of very few studies, all previous transcriptomic analyses on the pneumococcus were carried out using lab-adapted strains such as D39 or TIGR4. Our study is one of the first to investigate the transcriptomes of serotype 1 (S1) pneumococci. We took the most basic approach of growing S. pneumoniae in brain heart infusion medium using three distinct strains, i.e. sequence type ST306, ST217 and ST615, as representative isolates of the European, African and South American S1 clusters. As a follow-up to our recent studies on these three lineages, we sought to investigate their respective in vitro transcriptomic profiles in comparison to D39. In total, 292 genes showed significant differential expression in the exponential growth phases of all three S1 isolates compared to D39. A total of 151 genes showed higher transcription levels while 141 genes presented lower expression. The most prominent functional groups showing higher expression included the competence pathway and purine metabolism, while lactose metabolism and iron/amino acid transport presented lower expression in serotype 1 strains. Our study provides novel insight into the signature gene expression associated with hypervirulent pneumococci S1 and highlight the need to perform transcriptomic analysis on pneumococcal strains other than lab-adapted strains.

2025-07-11 | GSE279694 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data